Nephrology Cover Articles
Patients with hemoglobin values of 9.7 g/dL or below had more than double the risk for hemorrhagic stroke compared with patients with hemoglobin values of 11.2 g/dL or above.
New findings suggest that national strategies have failed to correct racial/ethnic disparities in live donor kidney transplantation.
Early and late initiation of renal replacement therapy for AKI in critically ill patients are associated with similar long-term risks of death, chronic kidney disease, and end-stage renal disease.
Updated recommendations lower the blood pressure threshold for a hypertension diagnosis from 140/90 to 130/80 mm Hg.
HD patients with untreated or ineffectively treated anemia prior to dialysis initiation were more likely to die than those who had consistently well-treated anemia.
Even at very low levels, residual kidney function in hemodialysis patients clears uremic solutes.
Among hemodialysis patients always or nearly always bothered by itchy skin, 17% did not report their symptoms to a health care provider and 18% used no treatment for the condition.
AKI occurred with similar frequency among patients who did and did not receive contrast medium.
In a study of African Americans with hypertension-related CKD, metoprolol, but neither ramipril nor amlodipine, increased serum uric acid levels.
Stage G3b-5 chronic kidney disease independently predicted a nearly 2-fold increased risk recurrence and 3-fold increased risk of progression following transurethral resection.
International survey finds geographic variation in the subtype frequencies in biopsied patients.
Myocardial infarction patients who underwent percutaneous coronary intervention had an AKI rate similar to those who did not have the procedure.
Among other changes, the new KDIGO guidelines highlight the potential dangers of hypercalcemia.
Nephrolithiasis developed in 18,777 healthy men during 1,184,654 person-years of follow-up.
The adjusted 5-year risk of insulin use following donation is 5 times higher among obese vs normal weight donors.
In a phase 2b trial, around half of patients taking the novel calcineurin inhibitor at a dose of 23.7 mg twice daily achieved complete remission at 48 weeks.
In a study, vonapanitase did not improve primary patency compared with placebo, but did improve secondary patency and fistula use for hemodialysis.
Use of bioimpedance spectroscopy to assess volume depletion could be a factor, researchers say.
From 2015 to 2016, the number of organ transplants rose from 30,969 to 33,595; the number of kidney transplants increased from 17,878 to 19,061.
Copeptin, a surrogate marker for arginine vasopressin (AVP), showed prognostic value of established risk markers.
Patients feel better and recovery times are shorter with 6 hemodialysis sessions per week rather than 3, researchers report.
In a study, only 3 of 108 patients experienced complications, all of which were minor and required no hospitalization or further intervention.
Sparsentan could become the first FDA-approved medication for the focal segmental glomerularsclerosis.
Their risk of the rare but life-threatening condition is twice as high as in hemodialysis patients.
Mortality risk is similar whether starting treatment with 1 or 2 sessions per week or with the conventional 3 sessions per week.
Study reveals 6-fold higher risk of SHPT in patients on furosemide vs hydrochlorothiazide.
Black CKD patients with strict blood pressure control had a 19% lower risk of premature death.
Average weekly doses greater than 70 µg/week was associated with a 77% increased risk of cancer compared with no ESA exposure.
Highest vs lowest quartile of intake is associated with a 40% increased risk.
Each Hounsfield unit increase on CT is associated with a 7% decreased risk of death among waitlisted kidney transplant candidates.
Study demonstrates improved 90-day survival and greater likelihood of recovering renal function.
Diabetic nephropathy lesions may develop prior to the onset of clinical findings.
Use of the lipid-lowering drugs is associated with 43% and 47% decreased odds of new stones in recurrent stone formers and stone naïve patients.
After adjusting for potential confounders and mediators, a large cross-sectional study found no association between obesity and CKD prevalence.
Fellowship positions go unfilled as the US faces expanding population of kidney disease patients.
Survival rates are lower among patients who receive a deceased-donor kidney or remain on the transplant waiting list.
Trend started around the introduction of the Medicare prospective payment system for dialysis care.
In a study, the arrhythmia was 31% more likely to occur in PKD patients than non-PKD control patients.
Study shows benefit of initiating epoetin beta therapy at hemoglobin levels not less than 10 g/dL in non-dialysis CKD patients.
In a prospective study, prediabetes was an independent risk factor for hyperfiltration and increased albuminuria.
Just over half of kidneys from deceased ECD/DCD donors are not used, study finds.
It has a stronger association with future end-stage renal disease risk than past eGFR decline, large study shows.
High levels of soluble urokinase-type plasminogen activator receptor are associated with an elevated CKD risk in individuals with normal eGFR.
The condition also occurs more frequent on the day after the long interdialytic interval.
Elevated risk observed with total and supplemental, but not dietary, vitamin C intake.
Researchers find link in the non-dialysis population.
Fluid overload implicated as an important risk factor for hospital admission.
Large study shows the association is more pronounced with increasing age.
Daily home hemodialysis also decreases likelihood of hospitalization and technique failure.
Hemodialysis patients who undergo the procedure experience decreased risks of all-cause and cardiovascular mortality.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)